Management of vestibular migraine

作者: Alexandre R. Bisdorff

DOI: 10.1177/1756285611401647

关键词: AnesthesiaMedicineFlunarizineVerapamilValproic AcidHeadachesLamotrigineEpisodic ataxiaMigraineTopiramate

摘要: Vestibular migraine is considered to be the second most common cause of vertigo and spontaneous episodic vertigo. The duration attacks varies from seconds days, usually lasting minutes hours, they mostly occur independently headaches. Long-lasting individual are treated with generic antivertiginous antiemetic drugs. Specific antimigraine drugs unlikely very effective for rescue. mainstay management vestibular prophylactic medication. To date, there no controlled trials available; body knowledge builds on case series retrospective or observational studies. Most also used prevention choice medication should guided by its side effect profile comorbidities patients. Betablockers such as propanolol metoprolol preferred in patients hypertension but absence asthma. Anticonvulsants include topiramate when obese, valproic acid lamotrigine. Lamotrigine if more frequent than Calcium antagonists verapamil flunarizine. If have anxiety, tricyclic antidepressants amitryptiline nortryptiline SSRIs benzodiazepines clonazepam recommended. Acetazolamide rare genetic disorders related migraine-like ataxia; however, place still established. Nonpharmacological measures diet, sleep, hygiene avoidance triggers recommended migraine. rehabilitation might useful complications loss confidence balance visual dependence.

参考文章(78)
Alexandre R Bisdorff, Treatment of migraine related vertigo with lamotrigine an observational study. Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg. pp. 103- 108 ,(2004)
Levent Sinan Bir, Arif Celiker, Necdet Ardiç, Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients. Clinical Neuropharmacology. ,vol. 30, pp. 213- 217 ,(2007) , 10.1097/WNF.0B013E31803BB3EE
B. Baier, E. Winkenwerder, M. Dieterich, "Vestibular migraine": effects of prophylactic therapy with various drugs. A retrospective study. Journal of Neurology. ,vol. 256, pp. 436- 442 ,(2009) , 10.1007/S00415-009-0111-3
Susan P. Buckelew, Michael S. Shutty, Maria McMahon, Lisa Dawdy, Behavioral treatment of dizziness secondary to benign positional vertigo following head trauma Archives of Physical Medicine and Rehabilitation. ,vol. 72, pp. 473- 476 ,(1991) , 10.5555/URI:PII:000399939190190T
Carey D. Balaban, Joseph M. Furman, Dawn A. Marcus, Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Current Opinion in Neurology. ,vol. 16, pp. 5- 13 ,(2003) , 10.1097/01.WCO.0000053582.70044.E2
A. Eckhardt-Henn, C. Best, S. Bense, P. Breuer, G. Diener, R. Tschan, M. Dieterich, Psychiatric comorbidity in different organic vertigo syndromes. Journal of Neurology. ,vol. 255, pp. 420- 428 ,(2008) , 10.1007/S00415-008-0697-X
John Phillips, Neil Longridge, Arthur Mallinson, Gordon Robinson, Migraine and Vertigo: A Marriage of Convenience? Headache: The Journal of Head and Face Pain. ,vol. 50, pp. 1362- 1365 ,(2010) , 10.1111/J.1526-4610.2010.01745.X
H. K. Neuhauser, M. von Brevern, A. Radtke, F. Lezius, M. Feldmann, T. Ziese, T. Lempert, Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. ,vol. 65, pp. 898- 904 ,(2005) , 10.1212/01.WNL.0000175987.59991.3D
WM Mulleners, EP Chronicle, Anticonvulsants in Migraine Prophylaxis: A Cochrane Review: Cephalalgia. ,vol. 28, pp. 585- 597 ,(2008) , 10.1111/J.1468-2982.2008.01571.X
P.J. Goadsby, A.R. Charbit, A.P. Andreou, S. Akerman, P.R. Holland, Neurobiology of migraine. Neuroscience. ,vol. 161, pp. 327- 341 ,(2009) , 10.1016/J.NEUROSCIENCE.2009.03.019